Skip to main content

Table 5 Mean (SD) The Public and Patient Engagement Evaluation Tool item scoresa by responses to background questions (n = 47)

From: The Public and Patient Engagement Evaluation Tool: forward-backwards translation and cultural adaption to Norwegian

 

Level of awarenessb

Frequency of collaborationc

Frequency of interactiond

Stage of user involvmente

 

None/some

Mid-high

None/some

Often

Never/some

Often

None/begun

Established

Domain/item

(n = 33)

(n = 13)

(n = 31)

(n = 15)

(n = 32)

(n = 14)

(n = 12)

(n = 34)

Policies and Practice

 6 Explicit strategy

3.75 (0.76)

4.08 (0.76)

3.70 (0.84)

4.13 (0.52)

3.77 (0.76)

4.00 (0.78)

3.09 (0.94)

4.09 (0.51)**

 7 Strategy - recruitment

3.50 (0.88)

4.15 (1.14)*

3.40 (1.00)

4.27 (0.70)**

3.65 (0.95)

3.79 (1.12)

3.00 (1.10)

3.91 (0.87)*

 8 Clear resources

3.68 (1.09)

3.45 (1.04)

3.25 (1.07)

4.15 (0.80)*

3.75 (0.97)

3.38 (1.19)

2.83 (0.98)

3.78 (1.01)

 9 Adequate resources

3.29 (0.96)

3.33 (1.16)

3.13 (0.92)

3.62 (1.12)

3.40 (0.91)

3.09 (1.22)

3.00 (0.93)

3.39 (1.03)

 10 Reports

3.28 (1.10)

3.85 (0.90)

3.33 (1.11)

3.67 (0.98)

3.25 (1.11)

3.86 (0.86)

3.10 (0.99)

3.56 (1.08)

Participatory Culture

 12 Documents

3.93 (0.75)

4.08 (1.04)

3.70 (0.87)

4.47 (0.52)**

3.96 (0.64)

4.00 (1.18)

3.40 (0.97)

4.16 (0.72)*

 13 Structure

3.47 (1.07)

3.54 (1.13)

3.17 (1.10)

4.14 (0.66)**

3.55 (1.06)

3.36 (1.15)

3.36 (0.92)

3.53 (1.14)

 15 Clear responsibilities

3.61 (0.84)

3.85 (1.14)

3.41 (0.94)

4.20 (0.68)**

3.67 (0.80)

3.71 (1.20)

3.20 (1.03)

3.82 (0.87)

 16 Job descriptions

3.59 (0.71)

3.18 (1.17)

3.41 (0.94)

3.45 (0.93)

3.59 (0.78)

3.18 (1.08)

3.43 (0.79)

3.43 (0.98)

 17 Training/materials

3.00 (0.91)

3.22 (1.09)

2.86 (0.94)

3.42 (0.90)

3.08 (0.93)

3.00 (1.05)

2.90 (0.74)

3.13 (1.04)

 18 PPE training

3.42 (1.03)

3.85 (0.80)

3.32 (0.98)

4.00 (0.85)*

3.50 (0.02)

3.64 (0.93)

3.17 (1.12)

3.68 (0.91)

 19 Leaders commited

3.97 (0.82)

3.85 (1.21)

3.87 (0.94)

4.07 (0.96)

4.00 (0.86)

3.79 (1.12)

3.36 (1.12)

4.12 (0.81)

 20 Reports shared

3.46 (0.88)

3.55 (1.13)

3.52 (0.96)

3.43 (0.94)

3.59 (0.89)

3.25 (1.06)

3.38 (0.52)

3.52 (1.03)

Influence and Impact

 22 Organisation

3.00 (0.58)

3.54 (0.52)*

3.00 (0.59)

3.50 (0.52)*

3.08 (0.58)

3.36 (0.63)

3.00 (0.50)

3.24 (0.64)

 23 Leaders use input

3.08 (0.63)

3.64 (0.51)*

3.04 (0.62)

3.62 (0.51)*

3.16 (0.69)

3.42 (0.52)

2.89 (0.78)

3.36 (0.56)

 24 Equality

3.30 (1.09)

3.69 (0.63)

3.29 (1.05)

3.67 (0.82)

3.31 (1.07)

3.64 (0.75)

2.70 (1.16)

3.64 (0.82)*

 25 Voting rights

2.95 (1.16)

2.75 (1.49)

2.89 (1.23)

2.91 (1.30)

3.00 (1.11)

2.70 (1.49)

2.17 (1.17)

3.09 (1.20)

 26 PPE influence

2.82 (0.66)

3.17 (0.39)

2.86 (0.73)

3.08 (0.28)

2.90 (0.70)

3.00 (0.41)

2.67 (0.52)

3.00 (0.61)

 27 Management

2.69 (0.75)

3.00 (0.47)

2.83 (0.84)

2.82 (0.41)

2.85 (0.80)

2.80 (0.42)

–

2.83 (0.65)

Collaboration and Common Purpose

 29 Shared goals

3.20 (0.52)

4.10 (0.74)

3.45 (0.76)

3.60 (0.70)

3.45 (0.61)

3.60 (0.97)

3.40 (0.55)

3.52 (0.77)

 30 Collaboration

3.17 (0.78)

4.00 (0.47)

3.35 (0.88)

3.54 (0.66)

3.38 (0.87)

3.50 (0.67)

3.43 (0.79)

3.42 (0.81)

Final thoughts

 32 Appropriate level

3.40 (0.90)

3.46 (1.51)

3.19 (0.98)

3.87 (1.19)*

3.44 (0.88)

3.36 (1.50)

2.75 (1.14)

3.65 (0.98)*

 33 Uses resources

3.21 (0.99)

3.46 (1.45)

3.03 (1.05)

3.80 (1.15)*

3.28 (0.92)

3.29 (1.51)

2.67 (0.99)

3.50 (1.11)*

 34 Overall benefit

4.03 (0.73)

4.46 (0.66)

4.10 (0.79)

4.27 (0.59)

4.09 (0.78)

4.29 (0.61)

3.67 (0.78)

4.32 (0.64)*

  1. a The underlined results do not meet the hypotheses. Asterisks denote statistically significant differences for Mann Whitney U Test: *P < 0.05; **P < 0.01
  2. b How would you rate your level of awareness of the organisation’s overall approach to public and patient engagement: “completely unaware, low level of awareness, neither aware nor unaware, some level of awareness” versus “middle or a high level of awareness”
  3. c How often do you collaborate with employees that lead or support patient involvement: “not at all, infrequently, sometimes” versus “fairly or very frequently”
  4. d How often do you interact with patient representatives associated with the organisation: “not at all, infrequently, sometimes” versus “fairly or very frequently”
  5. e At what stage would you say your organisation is when it comes to routinely engaging the public and/or patients in its activities: “not at all, just beginning”. versus “established or well established”
  6. f 11, 14, 21, 28, 31 and 35 are questions with free text fields
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us